These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34352566)
1. Mesenchymal stem cells transplantation attenuates hyperuricemic nephropathy in rats. Li L; Cheng D; An X; Liao G; Zhong L; Liu J; Chen Y; Yuan Y; Lu Y Int Immunopharmacol; 2021 Oct; 99():108000. PubMed ID: 34352566 [TBL] [Abstract][Full Text] [Related]
2. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255 [TBL] [Abstract][Full Text] [Related]
3. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902 [TBL] [Abstract][Full Text] [Related]
4. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling. Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251 [TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936 [TBL] [Abstract][Full Text] [Related]
7. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats. Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237 [TBL] [Abstract][Full Text] [Related]
8. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation. Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy. Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603 [TBL] [Abstract][Full Text] [Related]
10. Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms. Zhao X; Wang J; Tang L; Li P; Ru J; Bai Y Bioengineered; 2021 Dec; 12(1):589-600. PubMed ID: 33517833 [TBL] [Abstract][Full Text] [Related]
11. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF- Liu P; Wang C; Wang Y; Zhang H; Liu B; Qiu X Biomed Res Int; 2021; 2021():2793823. PubMed ID: 34938805 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats. Liu N; Xu L; Shi Y; Fang L; Gu H; Wang H; Ding X; Zhuang S Oncotarget; 2017 May; 8(20):33807-33826. PubMed ID: 28442634 [TBL] [Abstract][Full Text] [Related]
13. EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy. Liu N; Wang L; Yang T; Xiong C; Xu L; Shi Y; Bao W; Chin YE; Cheng SB; Yan H; Qiu A; Zhuang S J Am Soc Nephrol; 2015 Nov; 26(11):2716-29. PubMed ID: 25788532 [TBL] [Abstract][Full Text] [Related]
14. Effect of Rhizoma Polygoni Cuspidati and Ramulus Cinnamomi compatibility on uric acid metabolism and urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in rats with hyperuricemia. Han B; Zhu CX; Shi W; Huang HZ; Hu XG; Zhou XM; Lei M; Li Z Chin J Integr Med; 2017 Jul; 23(7):535-542. PubMed ID: 28116659 [TBL] [Abstract][Full Text] [Related]
15. Chloroquine inhibits NLRP3 inflammasomes activation and alleviates renal fibrosis in mouse model of hyperuricemic nephropathy with aggravation by a high-fat-diet. Cui J; Hong P; Li Z; Lin J; Wu X; Nie K; Zhang X; Wan J Int Immunopharmacol; 2023 Jul; 120():110353. PubMed ID: 37276828 [TBL] [Abstract][Full Text] [Related]
16. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model. Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507 [TBL] [Abstract][Full Text] [Related]
17. Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice. Pan J; Zhang C; Shi M; Guo F; Liu J; Li L; Ren Q; Tao S; Tang M; Ye H; Ma L; Fu P J Ethnopharmacol; 2021 Jan; 264():113278. PubMed ID: 32841699 [TBL] [Abstract][Full Text] [Related]
18. A Novel Approach Based on Gut Microbiota Analysis and Network Pharmacology to Explain the Mechanisms of Action of Amatjan M; Li N; He P; Zhang B; Mai X; Jiang Q; Xie H; Shao X Drug Des Devel Ther; 2023; 17():107-128. PubMed ID: 36712944 [TBL] [Abstract][Full Text] [Related]
19. Astaxanthin attenuated hyperuricemia and kidney inflammation by inhibiting uric acid synthesis and the NF-κ B/NLRP3 signaling pathways in potassium oxonate and hypoxanthine-induced hyperuricemia mice. Zhuang J; Zhou X; Liu T; Zhang S; Yuan F; Zhang L; Yang Z; Chen Y Pharmazie; 2021 Nov; 76(11):551-558. PubMed ID: 34782040 [TBL] [Abstract][Full Text] [Related]
20. Renal herb formula protects against hyperuricemic nephropathy by inhibiting apoptosis and inflammation. Tang GY; Li S; Xu Y; Zhang C; Xu XY; Xu L; Wang N; Feng Y Phytomedicine; 2023 Jul; 116():154812. PubMed ID: 37167821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]